Institutional members access full text with Ovid®

HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells

Fausther-Bovendo, Huguesa,b; Sol-Foulon, Nathaliec; Candotti, Danield,*; Agut, Henrid; Schwartz, Olivierc; Debré, Patricea,b; Vieillard, Vincenta,b

doi: 10.1097/QAD.0b013e32832cb26b
Basic Science

Objective: HIV infection induces a progressive depletion of CD4+ T cells. We showed that NKp44L, a cellular ligand for an activating natural killer (NK) receptor, is expressed on CD4+ T cells during HIV infection and is correlated with both CD4 cell depletion and increase in viral load. NKp44L+CD4+ T cells are highly sensitive to the NK lysis activity. In contrast, HIV-infected CD4+ T cells are resistant to NK killing, suggesting that HIV-1 developed strategies to avoid detection by the host cell immunity.

Design: To assess whether viral protein can affect NKp44L expression, using Nef-deficient virus as well as a panel of recombinant vaccinia viruses expressing all HIV-1 viral proteins was tested. The involvement of Nef in the downmodulation of NKp44L was determined using defined mutants of Nef. Functional consequences of Nef on NK-cell recognition were evaluated by either 51Cr-release assays and degranulation assays in presence of anti-NKp44L mAb.

Results: We observed that during HIV-1 infection, noninfected CD4+ T cells exclusively expressed NKp44L, and demonstrate that Nef mediates NKp44L intracellular retention in HIV-infected cells. This has functional consequences on HIV-infected CD4+ T cells recognition by NK cells, causing a decreased susceptibility to NK cytotoxicity. Furthermore, experiments in presence of neutralizing NKp44L mAb revealed that Nef inhibitory effect on NK cytotoxicity mainly depends on the NKp44L pathway.

Conclusion: This novel escape mechanism could explain the resistance of HIV-infected cells to NK lysis and as a result play a key role in maintaining the HIV reservoir by avoiding recognition by NK cells.

aINSERM UMR945, Hôpital Pitié-Salpêtrière, France

bUniversité Pierre et Marie Curie (Paris-6), France

cDépartement de Virologie, Institut Pasteur, France

dLaboratoire de Virologie, Hôpital Pitié-Salpêtrière, Paris, France.

*Present address: National Health Service Blood and Transplant, Cambridge Blood Center, Cambridge, UK.

Received 22 December, 2008

Revised 11 March, 2009

Accepted 7 April, 2009

Correspondence to Vincent Vieillard, PhD, Laboratoire d'Immunologie Cellulaire et Tissulaire, INSERM UMR945, Hôpital Pitié-Salpêtrière, 83 Bv de l'Hôpital, 75013 Paris, France. Tel: +33 1 42 17 75 24; fax: +33 1 42 17 74 90; e-mail: vincent.vieillard@upmc.fr

© 2009 Lippincott Williams & Wilkins, Inc.